Healthcare Equipment and Supplies
Company Overview of Cervel Neurotech, Inc.
Cervel Neurotech, Inc. manufactures medical devices for non-invasive, non-pharmacologic, and non-systemic treatment for psychiatric and neurologic illnesses. It offers repetitive transcranial magnetic stimulation (rTMS), a technology based product that targets and stimulates more than one brain area, including areas that lie deeper in the brain. The company’s rTMS product includes multiple magnetic coils that are placed on the scalp to steer magnetic field towards the specific network of brain regions associated with a particular disorder. Its product is used for the treatment of depression, addiction, and pain. Cervel Neurotech, Inc. was formerly known as NeoStim, Inc. and changed its name ...
3698 Haven Avenue
Redwood City, CA 94063
Founded in 2008
Key Executives for Cervel Neurotech, Inc.
Chief Executive Officer, President and Director
Founder, Chief Medical Officer and Director
Director of Clinical Research Programs
Vice President of Marketing
Compensation as of Fiscal Year 2015.
Cervel Neurotech, Inc. Key Developments
Cervel Neurotech, Inc. Presents at 9th Annual The Neurotech Investing & Partnering Conference 2014, Apr-24-2014 02:30 PM
Mar 20 14
Cervel Neurotech, Inc. Presents at 9th Annual The Neurotech Investing & Partnering Conference 2014, Apr-24-2014 02:30 PM. Venue: The Ritz Carlton, 10 Avery St., Boston, Massachusetts, United States. Speakers: Eric Meier, President and CEO.
Cervel Neurotech, Inc. Signs Master Research Agreement with Neuroscience Center
Mar 5 14
Cervel Neurotech, Inc. announced the formation of a Master Research Agreement with the Danish Neuroscience Center at Aarhus University Hospital in Aarhus, Denmark. The agreement represents the first Cervel System placement into the European Union (EU) and initiates investigation of a second clinical indication, the treatment of chronic pain, using Cervel's multicoil repetitive transcranial magnetic stimulation (rTMS) technology. The five-year agreement provides the basis for a series of research protocols designed to reveal insights into the mechanisms underlying brain stimulation and pain perception, with the objective of developing new treatments for patients resistant to traditional pharmaceutical therapy. The first study aims to establish the safety and efficacy of the Cervel System for patients suffering from chronic neuropathic pain.
Cervel Neurotech, Inc. Presents at The 7th Annual OneMedForum San Francisco 2014 Conference, Jan-13-2014
Dec 23 13
Cervel Neurotech, Inc. Presents at The 7th Annual OneMedForum San Francisco 2014 Conference, Jan-13-2014 . Venue: Westin San Francisco Market Street, San Francisco, California, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions